Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2004 | 1 |
2005 | 1 |
2006 | 1 |
2007 | 1 |
2010 | 1 |
2011 | 1 |
2023 | 0 |
Search Results
6 results
Results by year
Page 1
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG).
Ann Oncol. 2011 Apr;22(4):827-834. doi: 10.1093/annonc/mdq445. Epub 2010 Sep 29.
Ann Oncol. 2011.
PMID: 20880999
Free article.
Clinical Trial.
A multicenter phase II study of the combination of irinotecan and gemcitabine in previously treated patients with small-cell lung cancer.
Agelaki S, Syrigos K, Christophylakis C, Boukovinas J, Varthalitis J, Pavlakou G, Athanasiadis A, Kouroussis C, Vardakis N, Maltezakis G, Milaki G, Georgoulias V; Lung Cancer Subgroup, Hellenic Oncology Research Group.
Agelaki S, et al. Among authors: boukovinas j.
Oncology. 2004;66(3):192-6. doi: 10.1159/000077994.
Oncology. 2004.
PMID: 15218309
Clinical Trial.
Item in Clipboard
Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial.
Kosmidis P, Mylonakis N, Nicolaides C, Kalophonos C, Samantas E, Boukovinas J, Fountzilas G, Skarlos D, Economopoulos T, Tsavdaridis D, Papakostas P, Bacoyiannis C, Dimopoulos M.
Kosmidis P, et al. Among authors: boukovinas j.
J Clin Oncol. 2002 Sep 1;20(17):3578-85. doi: 10.1200/JCO.2002.12.112.
J Clin Oncol. 2002.
PMID: 12202657
Clinical Trial.
Item in Clipboard
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.
Kosmidis P, Fountzilas G, Baka S, Samantas E, Dimopoulos AM, Gogas H, Skarlos D, Papacostas P, Boukovinas J, Bakogiannis Ch, Pantelakos P, Athanasiou H, Misailidou D, Tsekeris P, Pavlidis N.
Kosmidis P, et al. Among authors: boukovinas j.
Anticancer Res. 2007 Nov-Dec;27(6C):4391-5.
Anticancer Res. 2007.
PMID: 18214050
Free article.
Clinical Trial.
Item in Clipboard
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer.
Stathopoulos GP, Syrigos K, Aravantinos G, Polyzos A, Papakotoulas P, Fountzilas G, Potamianou A, Ziras N, Boukovinas J, Varthalitis J, Androulakis N, Kotsakis A, Samonis G, Georgoulias V.
Stathopoulos GP, et al. Among authors: boukovinas j.
Br J Cancer. 2006 Sep 4;95(5):587-92. doi: 10.1038/sj.bjc.6603301. Epub 2006 Aug 8.
Br J Cancer. 2006.
PMID: 16909140
Free PMC article.
Clinical Trial.
Item in Clipboard
Sequential versus alternating administration of cisplatin/etoposide and topotecan as first-line treatment in extensive-stage small-cell lung cancer: preliminary results of a Phase III Trial of the Hellenic Oncology Research Group.
Ignatiadis M, Mavroudis D, Veslemes M, Boukovinas J, Syrigos K, Agelidou M, Agelidou A, Gerogianni A, Pavlakou G, Tselepatiotis E, Nikolakopoulos J, Georgoulias V.
Ignatiadis M, et al. Among authors: boukovinas j.
Clin Lung Cancer. 2005 Nov;7(3):183-9. doi: 10.3816/CLC.2005.n.034.
Clin Lung Cancer. 2005.
PMID: 16354313
Clinical Trial.
Item in Clipboard
Cite
Cite